Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lithium for prevention of chemotherapy-induced peripheral neuropathy in breast cancer
IRCT20160813029327N10Phase 3Completed
- Sponsor
- Islamic Azad University
- Start
- Apr 2018
- Modality
- DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in chemotherapy-induced peripheral neuropathy (CIPN) comparing Lithium with Placebo (2 arms). Primary endpoints: Peripheral neuropathy by EMG/NCV and Peripheral neuropathy score. Started Apr 2018; status: completed.
02
Drugs
lithium
03
Conditions
chemotherapy-induced peripheral neuropathy (CIPN)
Beyond the preview
Go deeper on IRCT20160813029327N10.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20160813029327N10.